Stock research
NRXS NeurAxis, Inc.
Healthcare • Biotechnology
NeurAxis, Inc. (NRXS) is an American company specializing in neuromodulation therapy devices. Its primary offering is IB-Stim, a percutaneous electrical nerve field stimulation system engineered to alleviate...…
NeurAxis, Inc. (NRXS) is an American company specializing in neuromodulation therapy devices. Its primary offering is IB-Stim, a percutaneous electrical nerve field stimulation system engineered to alleviate functional abdominal pain associated with irritable bowel syndrome in patients aged 11 to 18. NeurAxis markets its solutions to healthcare providers, predominantly hospitals and clinics. The firm, headquartered in Carmel, Indiana, was established in 2011 and operated as Innovative Health Solutions, Inc. until its rebranding to NeurAxis, Inc. in March 2022.
3M change
-19.33%
Range high
$8.81
Congress · 90d
0
Insiders · 90d
0
Public signal layer
Who is disclosing activity in NRXS?
Price
Showing 3M history. Source: FMP historical price full.
- Prev Close
- $6.59
- Day High
- $7.15
- Day Low
- $6.65
- 52w High
- $9.33
- 52w Low
- $2.20
- Volume
- 156,043
- Avg Volume
- Beta
- 1.418
* TTM/most recent where available
Company
- Ticker
- NRXS
- Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- US
- CEO
- Brian Carrico
- Employees
- 24
- Website
- neuraxis.com
Key Metrics
- Market Cap
- 87.5M
- P/E
- P/B
- P/S
- EV/EBITDA
- ROE
- Net Margin
- Div Yield
- FCF/Share
* TTM/most recent where available
DCF Valuation
Standard DCF
Levered DCF
Market Price
DCF vs Price (30D window)
Price uses last 30 days; DCF line holds latest value across the window.DCF line = solid green (latest value repeated across window), Price = dashed blue (daily closes).